Metabolički sindrom - novi pristup u definiranju i liječenju

Stručni rad - Pregledni rad

• Autor: Martina Šarić
• Autor: Monika Škunca
• Autor: Maja Ortner Hadžiabdić
• Autor: Velimir Božikov
• Autorova ustanova: Sveučilište u Zagrebu; Farmaceutsko-biokemijski fakultet; (Centar za primijenjenu farmaciju)
• Znanstveno / umjetničko područje, polje i grana: BIOMEDICINA I ZDRAVSTVO; Farmacija; Farmacija

Sažetak (engleski)

Metabolic syndrome (MS) is a combination of medical disorders that, when
occuring together, increase the risk of developing cardiovascular disease and diabetes.
Its prevalence has increased and it has become a significant public health issue around
the world. The definition of MS varies among different organisations. The consensus
has been made among the two most influential definitions (IDF and NCEP/ATPIII),
and the diagnosis of MS could be established if any three of five factors were present;these are abdominal obesity measured as waist circumference, elevated triglycerides,
reduced HDL-C, elevated blood pressure, and elevated fasting glucose.
Management of MS focuses on recognizing patients with MS and introducing
measures to decrease their risk factors. Primary recommendations are lifestyle changes
(healthy diet and physical activity), but pharmacology treatment (i.e. antihypertensive,
antidiabetic, antihyperlipidemic) for specific condition is indicated if lifestyle changes
were not effective and did not result in the recommended goals. The role of the pharmacist
is very important in identifying patients with MS, educating patients about
lifestyle changes, monitoring the progress and referral to other healthcare providers,
if needed.

• Ključne riječi (hrvatski): metabolički sindrom; inzulinska rezistencija; dislipidemija; hipertenzija; disglikemija; visceralna pretilost
• Jezik: hrvatski
• Vrsta publikacije: Stručni rad - Pregledni rad
• Status objave: Objavljen
• Vrsta recenzije: Recenziran - domaća recenzija
• Verzija publikacije: Objavljena verzija rada (izdavačev PDF)
• Naslov časopisa: Farmaceutski glasnik
• Brojčani podaci: vol. 69, br. 5, str. 333-345
• p-ISSN: 0014-8202
• URN:NBN: urn:nbn:hr:163:229931
• Datum objave publikacije: 2013
• Vrsta resursa: Tekst
• Prava pristupa: Otvoreni pristup
• Datum i vrijeme pohrane: 2020-09-30 13:30:54